Recorded Presentations from the NCCN 2012 Congress Webinar Series: Lung Cancers™: Management of Extensive-Stage Disease (Small Cell Lung Cancer)

This archived educational webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCLC). Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This activity is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with lung cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe appropriate treatment regimens for patients with extensive-stage SCLC
  • Select the most appropriate therapy for patients with extensive-stage SCLC
Additional information
Supporters: 

This activity is supported by an educational donation provided by Amgen. This program is supported by education grants from Astellas, Celgene Corporation, Genentech, Lilly USA, LLC, and Pfizer.

Course summary
Available credit: 
  • 0.50 Participation
  • 0.60 Nurse
  • 0.50 Pharmacist
  • 0.50 Physician
Course opens: 
07/03/2012
Course expires: 
07/03/2013
Cost:
$0.00

Gregory P. Kalemkerian, MD
University of Michigan Comprehensive Cancer Center

Available Credit

  • 0.50 Participation
  • 0.60 Nurse
  • 0.50 Pharmacist
  • 0.50 Physician

Price

Cost:
$0.00
Please login or register to take this course.